Effect of Age on Procedural Success, Complications, and Clinical Outcome From a Large Angioplasty Registry Publisher Pubmed



Mousavi M^{1, 2} ; Poorhosseini H¹ ; Nematipour E¹ ; Kassaian SE^{1, 2} ; Salarifar M^{1, 2} ; Alidoosti M^{1, 2} ; Hajizeinali A^{1, 2} ; Nozari Y^{1, 2} ; Amirzadegan A^{1, 2} ; Hosseini SK^{1, 2} ; Fathollahi MS³ ; Movahed MR^{4, 5}
Source: Critical Pathways in Cardiology Published:2019

Abstract

Background: Increasing age appears to be a risk factor for adverse outcome in patients undergoing percutaneous coronary intervention (PCI). The goal of this study was to compare procedural success, complications, and 12 months major adverse cardiac events (MACE) based on age using a large angioplasty registry. Methods: This registry included 10,412 patients with at least 12-month follow-up from April 1993 to April 2011. Patients were divided into 3 age groups: group 1 age < 60 (n = 6195), group 2 age 60-75 (n = 3724) and group 3 elderly age ≥ 75 (n = 493). Results: Procedural success rate was not significantly different across the 3 age groups. (96.9% in group 1, 97.1% in group 2, and 96.1% in elderly group, P = 0.759). Procedural complications occurred in 179 (2.9%) of group 1, 98 (2.6%) of group 2 and 15 (3.0%) of elderly group (P = 0.678). In-hospital complications increased with increasing age (311 [5.0%] in group 1, 235 [6.3%] in group 2, and 46 [9.3%] in elderly group; P < 0.001). Twelve-month MACE also increased with increasing age (235 [4.1%] in group 1, 169 [4.9%] in group 2 and 26 [5.7%] in elderly group; P = 0.021). Multivariate analysis showed that age was not a predictor for unsuccessful PCI, procedural complications, or 12-month MACE. However, increasing age was independent predictors of in-hospital complications and death. Conclusion: Despite increased in-hospital complications with increasing age, procedural success, and complications were not higher in elderly. Our data suggest that PCI should not be denied in elderly if indicated with procedural safety similar to other age groups. © 2018 Wolters Kluwer Health, Inc.